Chief Scientific Officer of Richmond Research Institute dedicated to research furthering the science of clinical trials delivered through a network of collaborative research. The initial fifteen years of my career rising through London Teaching Hospitals progressing to Deputy Chief Pharmacist at Barts Health Trust; Seconded to academic research offices facilitating investigator-initiated studies supporting 400+ clinical trials. Transitioning to Start-up Biotech as CSO for five years, working on a disruptive manufacturing technology in cell therapy products for regenerative medicine leading the conversion of Science to Value, driving changes to UK law to accommodate our technology. In Parallel I am a Senior Visiting Lecture at KCL and a Senior and Expert Advisor to DHSC sitting on the British Pharmacopoeia Commission. Driven to deliver to new therapies to patients in need.
